PNC Financial Services Group
INDV icon

PNC Financial Services Group’s Indivior Pharmaceuticals INDV Stock Holding History

PNC Financial Services Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$690K Buy
16,810
+7,381
+78% +$268K ﹤0.01% 1584
2026
Q1 		$287K Buy
9,429
+1,944
+26% +$64.2K ﹤0.01% 2071
2025
Q4 		$269K Buy
7,485
+7,238
+2,930% +$221K ﹤0.01% 2089
2025
Q3 		$5.96K Buy
+247
New +$5.17K ﹤0.01% 4139
2023
Q3 		– Sell
-25
Closed -$595 – 4675
2023
Q2 		$595 Buy
+25
New +$573 ﹤0.01% 4571

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PNC Financial Services Group's INDV Position: Q2 2026 in Review

PNC Financial Services Group increased its Indivior Pharmaceuticals (INDV) stake by 78% in Q2 2026, buying an estimated $268K and bringing the position to 16,810 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

PNC Financial Services Group first reported a position in INDV in Q2 2023 and has held it in 5 quarters since. 140 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • PNC Financial Services Group held 16,810 shares of Indivior Pharmaceuticals worth $690K as of Q2 2026.
  • PNC Financial Services Group bought 7,381 Indivior Pharmaceuticals shares in Q2 2026, an estimated $268K.
  • Indivior Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1584 holding.
  • PNC Financial Services Group first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
  • 140 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.